Literature DB >> 8909440

Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: a retrospective study on 119 patients.

G De Michele1, F Perrone, A Filla, E Mirante, M Giordano, S De Placido, G Campanella.   

Abstract

We performed a retrospective study on a series of 119 of our patients who have Friedreich's disease to assess the predictive value of age at onset, gender, and left ventricular hypertrophy in regard to disease progression. Outcome variables were survival, time to loss of independent gait, and time to confinement in a wheelchair. Diabetes was considered to be an outcome variable when defining time to diabetes and an explanatory variable when testing its effect on survival. Eleven patients died. The median estimated survival from onset was 36 years, and the median time to loss of independent gait was 8 years and to confinement in a wheelchair was 15 years from onset. Nineteen patients developed diabetes after a median time of 16 years. The presence of left ventricular hypertrophy or diabetes significantly reduced survival based on univariate analysis. Onset at the age of < or = 20 years and the presence of left ventricular hypertrophy predicted a faster rate of progression of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8909440     DOI: 10.1212/wnl.47.5.1260

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

Review 2.  Friedreich's Ataxia: a review from a cardiology perspective.

Authors:  T Bourke; D Keane
Journal:  Ir J Med Sci       Date:  2011-08-07       Impact factor: 1.568

Review 3.  Spinocerebellar degenerations: an update.

Authors:  Susan L Perlman
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 4.  Clinical features of Friedreich ataxia.

Authors:  Martin B Delatycki; Louise A Corben
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

Review 5.  Evaluating the progression of Friedreich ataxia and its treatment.

Authors:  Martin B Delatycki
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

6.  Phosphorus-31 two-dimensional chemical shift imaging in the myocardium of patients with late onset of Friedreich ataxia.

Authors:  Christian Wolf; Sylvia Boesch; Bernhard Metzler; Helga Weirich-Schwaiger; Thomas Trieb; Michael F H Schocke
Journal:  Mol Imaging Biol       Date:  2007-11-14       Impact factor: 3.488

7.  A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design.

Authors:  Francesco Saccà; Giorgia Puorro; Antonella Antenora; Angela Marsili; Alessandra Denaro; Raffaele Piro; Pierpaolo Sorrentino; Chiara Pane; Alessandra Tessa; Vincenzo Brescia Morra; Sergio Cocozza; Giuseppe De Michele; Filippo M Santorelli; Alessandro Filla
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

8.  Frataxin mRNA isoforms in FRDA patients and normal subjects: effect of tocotrienol supplementation.

Authors:  Provvidenza Maria Abruzzo; Marina Marini; Alessandra Bolotta; Gemma Malisardi; Stefano Manfredini; Alessandro Ghezzo; Antonella Pini; Gianluca Tasco; Rita Casadio
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

Review 9.  Identifying potential functional impact of mutations and polymorphisms: linking heart failure, increased risk of arrhythmias and sudden cardiac death.

Authors:  Benoît Jagu; Flavien Charpentier; Gilles Toumaniantz
Journal:  Front Physiol       Date:  2013-09-20       Impact factor: 4.566

10.  Determinants of onset age in Friedreich's ataxia.

Authors:  G De Michele; A Filla; C Criscuolo; V Scarano; F Cavalcanti; L Pianese; A Monticelli; S Cocozza
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.